Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis
- Journal
- Nature Medicine
In The Last Decade
doi.org/10.1038/nm1124 →Countries where authors are citing Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis
This map shows the geographic impact of Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis more than expected).
Fields of papers citing Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis
This network shows the impact of Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis.
About Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis
This paper, published in 2004, received 943 indexed citations . Written by Hong Wang, Hong Liao, Mahendar Ochani, Xinchun Lin, Lihong Yang, Yousef Al‐Abed, Haichao Wang, Christine N. Metz, Edmund J. Miller and Kevin J. Tracey covering the research area of Neurology, Molecular Biology and Clinical Biochemistry. It is primarily cited by scholars working on Neurology (473 citations), Molecular Biology (467 citations) and Immunology (196 citations). Published in Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/10.1038/nm1124.